BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9701258)

  • 1. Donor-specific portal blood transfusion in intestinal transplantation: a prospective, preclinical large animal study.
    Gruessner RW; Nakhleh RE; Harmon JV; Dunning M; Gruessner AC
    Transplantation; 1998 Jul; 66(2):164-9. PubMed ID: 9701258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recipient preconditioning and donor-specific bone marrow infusion in a pig model of total bowel transplantation.
    Gruessner RW; Uckun FM; Pirenne J; Nakhleh RE; Benedetti E; Bekersky I; Troppmann C; Gruessner AC
    Transplantation; 1997 Jan; 63(1):12-20. PubMed ID: 9000654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow augmentation in kidney transplantation: a large animal study.
    Gruessner RW; Zhang KY; Dunning M; Nakhleh RE; Gruessner AC
    Transpl Int; 2001 Jun; 14(3):159-69. PubMed ID: 11499905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental short-term immunosuppression after bowel transplantation and donor-specific bone marrow infusion.
    Harmon JV; Gruessner AC; Nakhleh RE; Zhang K; Gruessner RW
    Arch Surg; 2001 Jul; 136(7):817-21. PubMed ID: 11448397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined transplantation of small and large bowel. FK506 versus cyclosporine A in a porcine model.
    Pirenne J; Benedetti E; Gruessner A; Moon C; Hakim N; Fryer JP; Troppmann C; Nakhleh RE; Gruessner RW
    Transplantation; 1996 Jun; 61(12):1685-94. PubMed ID: 8685944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portal donor-specific blood transfusion and mycophenolate mofetil allow steroid avoidance and tacrolimus dose reduction with sustained levels of chimerism in a pig model of intestinal transplantation.
    Gruessner RW; Levay-Young BK; Nakhleh RE; Shearer JD; Dunning M; Nelson CM; Gruessner AC
    Transplantation; 2004 May; 77(10):1500-6. PubMed ID: 15239611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined liver-total bowel transplantation has no immunologic advantage over total bowel transplantation alone. A prospective study in a porcine model.
    Gruessner RW; Nakhleh RE; Benedetti E; Pirenne J; Belani KG; Beebe D; Carr R; Troppmann C; Gruessner AC
    Arch Surg; 1997 Oct; 132(10):1077-85. PubMed ID: 9336505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation.
    Gruessner RW; Fryer JP; Fasola C; Nakhleh RE; Gruessner AC; Kim S; Dunn DL; Pirenne J; Bekersky I; Benedetti E
    Transplantation; 1995 Jan; 59(2):164-71. PubMed ID: 7530871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quadruple immunosuppression in a pig model of small bowel transplantation.
    Gruessner RW; Fasola C; Fryer J; Nakhleh RE; Kim S; Gruessner AC; Beebe D; Moon C; Troppmann C; Najarian JS
    J Surg Res; 1996 Feb; 61(1):260-6. PubMed ID: 8769976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-specific unmodified bone marrow transfusion does not facilitate intestinal engraftment after bowel transplantation in a porcine model.
    Pirenne J; Gruessner AC; Benedetti E; Troppmann C; Nakhleh RE; Uckun FM; Gruessner RW
    Surgery; 1997 Jan; 121(1):79-88. PubMed ID: 9001555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal graft versus native liver cytokine expression in a rat model of intestinal transplantation with and without donor-specific cell augmentation.
    Levay-Young B; Gruessner SE; Shearer JD; Cheol Kim S; Nahkleh RE; Gruessner RW
    J Surg Res; 2003 Sep; 114(1):78-89. PubMed ID: 13678702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete freedom from rejection after intestinal transplantation using a new tolerogenic protocol combined with low immunosuppression.
    Pirenne J; Koshiba T; Geboes K; Emonds MP; Ferdinande P; Hiele M; Nevens F; Waer M
    Transplantation; 2002 Mar; 73(6):966-8. PubMed ID: 11923701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.
    Cheigh JS; Suthanthiran M; Fotino M; Riggio RR; Schechter N; Stubenbord WT; Stenzel KH; Rubin AL
    Transplantation; 1991 Feb; 51(2):378-81. PubMed ID: 1825244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.
    Stegall MD; Wachs ME; Everson G; Steinberg T; Bilir B; Shrestha R; Karrer F; Kam I
    Transplantation; 1997 Dec; 64(12):1755-60. PubMed ID: 9422416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of donor-specific blood transfusion with cyclosporine in living related kidney transplantation.
    Otsuka M; Yuzawa K; Takada Y; Taniguchi H; Todoroki K; Fukao K; Koyama A; Akaza H
    Nephron; 2001 Jun; 88(2):144-8. PubMed ID: 11399917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined immunosuppressive therapy with tacrolimus and mycophenolate mofetil for small bowel transplantation in pigs.
    Alessiani M; Spada M; Dionigi P; Arbustini E; Regazzi M; Fossati GS; Zonta A
    Transplantation; 1996 Sep; 62(5):563-7. PubMed ID: 8830816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deoxyspergualin prophylaxis with tacrolimus further improves long-term graft survival in living-related renal-transplant recipients transfused with donor-specific blood.
    Amada N; Okazaki H; Sato T; Ohashi Y; Kikuchi H
    Transplant Proc; 2005 Mar; 37(2):927-9. PubMed ID: 15848577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial translocation in a large-animal model of small-bowel transplantation. Portal vs systemic venous drainage and the effect of tacrolimus immunosuppression.
    Fryer JP; Kim S; Wells CL; Fasola C; Jechorek RP; Dunn DL; Pirenne J; Arazola L; Gruessner RW
    Arch Surg; 1996 Jan; 131(1):77-84. PubMed ID: 8546583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small bowel transplantation. The effect of intraportal donor-specific transfusion 24 hours pretransplant and low-dose cyclosporine.
    Fecteau AH; Tchervenkov JI; Guttman FM; Takara T; Rosenmann E
    Transplantation; 1994 Aug; 58(4):399-402. PubMed ID: 8073506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.